ALBUTROPIN

Serial Number 76081975
606

Registration Progress

Application Filed
Jun 30, 2000
Under Examination
Jul 17, 2001
Approved for Publication
Apr 11, 2001
Published for Opposition
Apr 24, 2001
Registered

Basic Information

Serial Number
76081975
Filing Date
June 30, 2000
Published for Opposition
April 24, 2001
Abandonment Date
July 18, 2004
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 18, 2004
Classes
005

Rights Holder

Principia Pharmaceutical Corporation

03
Address
2650 Eisenhower Avenue
Norristown, PA 19403

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Principia Pharmaceutical Corporation

Original Applicant
03
Norristown, PA

HUMAN GENOME SCIENCES, INC.

New Owner Before Publication #1
03
ROCKVILLE, MD

Principia Pharmaceutical Corporation

Owner at Publication
03
Norristown, PA

Legal Representation

Attorney
CHRISTY BATY HEINZE

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

21 events
Date Code Type Description
Sep 16, 2004 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jul 1, 2004 CFIT O CASE FILE IN TICRS
Feb 16, 2004 EX5G S SOU EXTENSION 5 GRANTED
Jan 20, 2004 MAIL I PAPER RECEIVED
Jan 17, 2004 EXT5 S SOU EXTENSION 5 FILED
Aug 26, 2003 EX4G S SOU EXTENSION 4 GRANTED
Jul 17, 2003 MAIL I PAPER RECEIVED
Jul 17, 2003 EXT4 S SOU EXTENSION 4 FILED
Apr 11, 2003 EX3G S SOU EXTENSION 3 GRANTED
Jan 17, 2003 MAIL I PAPER RECEIVED
Jan 17, 2003 EXT3 S SOU EXTENSION 3 FILED
Aug 8, 2002 EX2G S SOU EXTENSION 2 GRANTED
Jul 17, 2002 MAIL I PAPER RECEIVED
Jul 17, 2002 EXT2 S SOU EXTENSION 2 FILED
Jan 14, 2002 EX1G S SOU EXTENSION 1 GRANTED
Dec 14, 2001 EXT1 S SOU EXTENSION 1 FILED
Jul 17, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 24, 2001 PUBO A PUBLISHED FOR OPPOSITION
Apr 11, 2001 NPUB O NOTICE OF PUBLICATION
Dec 4, 2000 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 28, 2000 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATION, NAMELY FUSION PROTEIN FOR TREATMENT OF GROWTH HORMONE DEFICIENCY
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005